Lu Yi, Qi Jianping, Dong Xiaochun, Zhao Weili, Wu Wei
School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery of MOE and PLA, Shanghai, China.
School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery of MOE and PLA, Shanghai, China; Key Laboratory for Special Functional Materials of the Ministry of Education, Henan University, Kaifeng, China.
Drug Discov Today. 2017 Apr;22(4):744-750. doi: 10.1016/j.drudis.2017.01.003. Epub 2017 Jan 11.
There has been significant research interest in, and development of, nanocrystals in recent years for the delivery of poorly water-soluble drugs via various routes. However, there is a common misinterpretation of nanocrystallization as an approach to modulate, and more specifically to enhance, the dissolution of drug crystals. Nevertheless, it is possible for nanocrystals to interact with biological tissues because nanocrystals can survive for a longer duration in vivo compared with solution counterparts. Therefore, understanding the in vivo fate of nanocrystals and determining its contribution to efficacy is of tremendous significance for optimizing the performance of nanocrystals. Here, we critically review the general hypotheses related to the in vivo fate of nanocrystals.
近年来,人们对纳米晶体产生了浓厚的研究兴趣,并致力于其开发,以通过各种途径递送水溶性差的药物。然而,人们普遍将纳米结晶误解为一种调节,更具体地说是增强药物晶体溶解的方法。尽管如此,纳米晶体有可能与生物组织相互作用,因为与溶液形式的对应物相比,纳米晶体在体内可以存活更长时间。因此,了解纳米晶体的体内命运并确定其对疗效的贡献对于优化纳米晶体的性能具有极其重要的意义。在此,我们批判性地综述了与纳米晶体体内命运相关的一般假设。